2023年研究論文

研究論文

作者
(順位)
論文題目 發表之雜誌期刊
(含年月/卷期/頁次)
黃冠華(1) In Silico Analysis of Anti-Inflammatory and Antioxidant Properties of Bioactive Compounds from Crescentia cujete L Molecules . 2023 Apr 18;28(8):3547
黃冠華(5) Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma Front Biosci (Landmark Ed). 2023 Apr 19;28(4):75.
黃冠華(4) Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker Diagnostics (Basel) . 2023 Jul 6;13(13):2296.
黃冠華(1) An In Vitro Evaluation and Network Pharmacology Analysis of Prospective Anti-Prostate Cancer Activity from Perilla frutescens Plants (Basel) . 2023 Aug 21;12(16):3006.
黃冠華(1) In Silico Neuroprotective Effects of Specific Rheum palmatum Metabolites on Parkinson's Disease Targets Int J Mol Sci . 2023 Sep 11;24(18):13929.
黃冠華(1) Antioxidant, Anti-Inflammatory and Antiproliferative Effects of Osmanthus fragrans (Thunb.) Lour. Flower Extracts Plants (Basel) . 2023 Sep 4;12(17):3168.
黃冠華(6) Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma Sci Rep . 2023 Oct 14;13(1):17444.
黃冠華(6) LAMC2 is a potential prognostic biomarker for cholangiocarcinoma Oncol Lett . 2023 Oct 30;26(6):533.
黃冠華(6) Sesamin: A Promising Therapeutic Agent for Ameliorating Symptoms of Diabetes Molecules . 2023 Oct 25;28(21):7255.
黃冠華(5) Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma Eur J Med Res . 2023 Dec 15;28(1):593.
黃冠華(4)
劉建良(5)
Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma Front Oncol . 2023 Feb 24:13:944321.
黃冠華(5)
謝昆霖(6)
Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder World J Surg Oncol . 2023 Feb 25;21(1):62.
黃冠華(6)
謝昆霖(7)
曾文歆(8)
Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma BMC Cancer . 2023 Jun 28;23(1):599.
黃冠華(4)
曾文歆(5)
Impact of pathological response on oncological outcomes in patients with upper tract urothelial cancer receiving neo-adjuvant chemotherapy J Formos Med Assoc . 2023 Dec;122(12):1274-1281.
劉建良(1) CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma PLoS One . 2023 Mar 2;18(3):e0281873
蘇家震(2) Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway Am J Chin Med . 2023;51(4):1019-1039.
蘇家震(4) Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways Biomed Pharmacother . 2022 Dec:156:113929.
王致丞(3,C) Photonic crystal enhanced immunofluorescence biosensor integrated with a lateral flow microchip: Toward rapid tear-based diabetic retinopathy screening Biomicrofluidics . 2023 Jul 20;17(4):044102.
李高漢(2) Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients-When Intravesical Botox Injection or Urethral Botox Injection Are Indicated Toxins (Basel) . 2023 Apr 17;15(4):288.
李高漢(8) Clinical Guidelines of Patient-centered Bladder Management of Neurogenic Lower Urinary Tract Dysfunction due to Chronic Spinal Cord Injury-Part 2: Conservative and Minimally Invasive Treatment Urological Science. 34(1):10-17, Jan-Mar 2023.
林才揚(1,C)
劉建良(2)
黃冠華(3)
Laparoscopic excision of huge seminal vesicle cyst in zinner syndrome Radiol Case Rep. 2023 Jun; 18(6): 2172–2175.
蔡易辰(1)
謝育哲(2,C)
曾文歆(3)
劉建良(4)
黃冠華(8)
Retroperitoneal laparoscopic adrenalectomy for large adrenal tumors-analysis of tumor size and adverse events: a retrospective single-center study Front Surg . 2024 Jan 5:10:1284093.
謝佳駤(1)
曾文歆(2,C)
劉建良(3)
蘇家震(4)
黃冠華(7)
Early Postoperative Outcomes of Retroperitoneal Partial Nephrectomy of Anterior and Posterior Renal Tumors: A 5-Year Experience in A Single Center J Endourol . 2023 May;37(5):557-563.

列印